Table 3. Serological follow-up of patients treated with antibiotic therapy.
| Patient N° | Samplesa | Blood Culture | Glycoconjugate-beads assay (%)b | CELISA (%I)c | FCd |
| 28 | a(0) | Negative | 155.1 | 81 | 320 |
| b(2) | 85.6 | 66 | 80 | ||
| c(4) | 50.7 | 48 | 40 | ||
| d(7) | 26.8 | 46 | 40 | ||
| 36 | a(0) | Negative | 113.4 | 74 | 160 |
| b(7) | 41.5 | 56 | 20 | ||
| c(11) | 51.1 | 45 | 5 | ||
| d(16) | 17.9 | 42 | 5 | ||
| e(19) | 40.2 | 45 | 5 | ||
| f(23) | 35.6 | 40 | 5 | ||
| 1 | a(0) | B. suis bv 1 | 79.3 | 76 | 1280 |
| b(2) | 133.6 | 76 | 640 | ||
| c(5) | 255.9 | 94 | 1280 | ||
| d(9) | 296.9 | 91 | 640 | ||
| e(13) | 223.3 | 92 | 320 | ||
| f(17) | 201.1 | 81 | 160 | ||
| g(20) | 137.0 | 55 | 80 | ||
| h(23) | 151.9 | 60 | 80 | ||
| i(26) | 111.8 | 73 | 40 | ||
| j(29) | 122.4 | 75 | 40 | ||
| 3 | a(0) | B. suis bv 1 | 105.9 | 63 | 320 |
| b(13) | 302.3 | 91 | 160 | ||
| c(17) | 226.9 | 89 | 160 | ||
| d(20) | 232.1 | 85 | 80 | ||
| e(30) | 111.7 | 72 | 20 | ||
| f(32) | 126.8 | 71 | 20 | ||
| 6 | a(0) | B. abortus bv 1 | 102.2 | 64 | 320 |
| b(3) | 65.6 | 61 | 80 | ||
| c(8) | 58.5 | 48 | 40 | ||
| 7 | a(0) | B. suis bv 1 | 121.6 | 64 | 160 |
| b(2) | 167.4 | 74 | 320 | ||
| c(6) | 74.6 | 52 | 40 | ||
| 10 | a(0) | B. abortus bv 2 | 69.9 | 65 | 10 |
| b(5) | 27.0 | 45 | 5 | ||
| c(10) | 22.3 | 43 | NEG | ||
| d(12) | 15.5 | 30 | NEG | ||
| 37 | a(0) | Negative | 129.2 | 68 | 80 |
| b(2) | 77.1 | 48 | 80 | ||
| c(3) | 82.6 | 52 | 40 | ||
| d(6) | 72.8 | 62 | 20 | ||
| e(10) | 47.0 | 60 | 20 | ||
| f(32) | 24.5 | 49 | 10 | ||
| 39 | a(0) | Negative | 158.8 | 88 | 160 |
| b(3) | 237.5 | 92 | 320 | ||
| c(4) | 249.3 | 93 | 640 | ||
| d(6) | 151.2 | 92 | 320 | ||
| e(8) | 125.9 | 91 | 80 | ||
| f(10) | 80.7 | 88 | 80 | ||
| g(13) | 68.9 | 82 | 20 | ||
| h(20) | 41.1 | 75 | 5 | ||
| i(31) | 25.4 | 65 | 5 |